{"id":179455,"date":"2026-02-03T15:25:44","date_gmt":"2026-02-03T20:25:44","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=179455"},"modified":"2026-02-03T15:25:44","modified_gmt":"2026-02-03T20:25:44","slug":"rubicon-research-reports-52-revenue-growth-in-q3-fy26-profit-nearly-doubles","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/rubicon-research-reports-52-revenue-growth-in-q3-fy26-profit-nearly-doubles\/","title":{"rendered":"Rubicon Research Reports 52% Revenue Growth in Q3 FY26; Profit Nearly Doubles"},"content":{"rendered":"\n<p>Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price levels, intraday percentage move, and 52-week trading range were not disclosed in the company\u2019s investor presentation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Quarterly Performance Overview<\/h2>\n\n\n\n<p>Rubicon Research reported a strong set of consolidated results for the quarter ended December 31, 2025, driven by broad-based revenue growth and sustained operating margins. Revenue from operations rose 51.7% year-on-year to \u20b94,755 million, compared with \u20b93,134 million in Q3 FY25. EBITDA increased 59.0% to \u20b91,119 million, while profit after tax nearly doubled to \u20b9728 million, up 91.2% year-on-year. Fully diluted earnings per share rose to \u20b94.41, from \u20b92.46 a year earlier.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Margins and Cost Structure<\/h2>\n\n\n\n<p>Operating EBITDA margin stood at 22.7%, broadly stable compared with 22.3% in Q3 FY25, despite a sequential decline in gross margin due to higher reliance on outsourced manufacturing. Gross margin for the quarter was impacted by capacity constraints, though management indicated operating margins remained resilient in the 22\u201323% range. R&amp;D expenditure rose to \u20b9523 million, representing 11.0% of operating revenue, compared with 8.3% a year earlier, reflecting continued investment in product development.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Nine-Month and Year-on-Year Context<\/h2>\n\n\n\n<p>For the nine months ended December 31, 2025, revenue increased 33.9% year-on-year to \u20b912,400 million, while PAT rose 73.2% to \u20b91,700 million. EBITDA for the nine-month period climbed 46.8% to \u20b92,867 million, with EBITDA margin expanding to 23.1%.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Business Drivers and Visibility<\/h2>\n\n\n\n<p>The company reported USD revenue of $53 million, up 46% year-on-year, with approximately 98% of revenue denominated in U.S. dollars. Top-10 products contributed 53% of quarterly revenue, reflecting a broadening product base, while 93% of approved products have been commercialised.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Analyst Actions<\/h2>\n\n\n\n<p>The investor presentation did not report any analyst upgrades, downgrades, or price-target changes following the Q3 FY26 results.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price levels, intraday percentage move, and 52-week trading range were not disclosed in the company\u2019s investor presentation. Quarterly Performance Overview Rubicon Research reported a strong set of consolidated results for the quarter ended December 31, 2025, [&hellip;]<\/p>\n","protected":false},"author":2384,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1941,392,5747],"tags":[10141,8157],"class_list":["post-179455","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-analysis","category-earnings","category-healthcare-stocks","tag-drug-manufacturers-general","tag-healthcare"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":179200,"url":"https:\/\/alphastreet.com\/india\/latent-view-analytics-limited-shares-jump-on-q3-fy26-results-revenue-rises-22\/","url_meta":{"origin":179455,"position":0},"title":"Latent View Analytics Limited Shares Jump on Q3 FY26 Results; Revenue Rises 22%","author":"Staff Correspondent","date":"February 2, 2026","format":false,"excerpt":"Latent View Analytics Limited (NSE: LATENTVIEW) shares jumped as much as 7\u20138% in early trade on Monday after the Indian analytics firm reported strong quarterly results for the period ended December 31, 2025. The stock traded around \u20b9447\u2013\u20b9452 on the National Stock Exchange, up about 7% intraday, supported by upbeat\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":178238,"url":"https:\/\/alphastreet.com\/india\/gland-pharma-limited-q3-fy26-revenue-rises-22-shares-steady-in-early-trade\/","url_meta":{"origin":179455,"position":1},"title":"Gland Pharma Limited Q3 FY26 Revenue Rises 22%, Shares Steady in Early Trade","author":"Staff Correspondent","date":"January 28, 2026","format":false,"excerpt":"Gland Pharma Limited (NSE: GLAND) shares were trading around \u20b91,688, up about 0.8% in early Wednesday deals, after the Hyderabad-based injectables maker reported its third-quarter results. The stock trades well below its 52-week high of \u20b92,131 and above its 52-week low near \u20b91,278, reflecting a sideways to slightly softer trend\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":88645,"url":"https:\/\/alphastreet.com\/india\/infosys-infy-q3-earnings-key-numbers-and-performance\/","url_meta":{"origin":179455,"position":2},"title":"Infosys (INFY) Q3 Earnings: Key numbers and performance","author":"Shreya","date":"January 13, 2021","format":false,"excerpt":"Infosys Limited (NYSE: INFY) reported third-quarter 2021 earnings results Wednesday. Revenue increased to $3.5 billion from $3.2 billion last year. Analysts had expected revenue of $3.38 billion. The net profit rose to $705 million from $626 million, while earnings per share increased from $0.15 to $0.17, compared to analysts' estimate\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/01\/Infosys-Q3-2021-earnings-infograph.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/01\/Infosys-Q3-2021-earnings-infograph.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/01\/Infosys-Q3-2021-earnings-infograph.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/01\/Infosys-Q3-2021-earnings-infograph.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/01\/Infosys-Q3-2021-earnings-infograph.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":181077,"url":"https:\/\/alphastreet.com\/india\/rbz-jewellers-q3-earnings-surge-retail-revival-stuns\/","url_meta":{"origin":179455,"position":3},"title":"RBZ Jewellers Q3 Earnings Surge: Retail Revival Stuns","author":"Staff Correspondent","date":"February 16, 2026","format":false,"excerpt":"RBZ Jewellers (BSE: 544060, NSE: RBZJEWEL) is a leading organized manufacturer of gold jewellery in India. RBZ Jewellers Q3 FY26 earnings exceeded expectations with robust festive and wedding season demand. The company delivered improved performance across retail, wholesale, and job work segments. Official RBZ Jewellers Q3 FY26 Earnings Presentation Market\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":178256,"url":"https:\/\/alphastreet.com\/india\/sagility-limited-shares-trade-lower-after-q3-fy26-results-revenue-up-35-7-yoy\/","url_meta":{"origin":179455,"position":4},"title":"Sagility Limited Shares Trade Lower After Q3 FY26 Results; Revenue Up 35.7% YoY","author":"Staff Correspondent","date":"January 28, 2026","format":false,"excerpt":"Sagility Limited (NSE: SAGILITY) shares slipped in early trade on Wednesday after the company reported a strong set of third-quarter fiscal 2026 results. The stock was last quoted around \u20b951.7, down modestly on the day, after recent strength from earlier earnings momentum. The share price remains within a 52-week range\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":180012,"url":"https:\/\/alphastreet.com\/india\/man-industries-india-limited-reports-strong-q3-fy26-earnings-as-margins-expand-and-order-book-rises\/","url_meta":{"origin":179455,"position":5},"title":"Man Industries (India) Limited reports strong Q3 FY26 earnings as margins expand and order book rises","author":"Staff Correspondent","date":"February 9, 2026","format":false,"excerpt":"Man Industries (India) Limited (NSE: MANINDS, BSE: 513269) reported a sharp increase in revenue, profit and margins for the quarter ended Dec. 31, 2025, supported by a stronger product mix, improved operating leverage and steady execution across domestic and export markets, according to the company\u2019s Q3\/9M FY26 earnings presentation. Q3\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2384"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179455"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179455\/revisions"}],"predecessor-version":[{"id":179457,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179455\/revisions\/179457"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}